Sullivan N F, Willis A E, Moore J P, Lindahl T
Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hert, U.K.
Oncogene. 1989 Dec;4(12):1509-11.
Lymphoblastoid cell lines derived from cancer prone Bloom's Syndrome patients differ from cell lines representative of several other disorders by exhibiting a constitutive elevation in the level of the c-myc protein. This may be a contributing factor in the strong predisposition to malignancy observed in Bloom's syndrome.